THOUSANDS of diabetics could be effectively “cured” thanks to a major breakthrough by Scottish scientists.
Patients could now have an islet cell transplant to prevent life-threatening complications including seizures.
The breakthrough enables scientists to take cells from the pancreas and change their function to produce insulin.
The research was carried out by the University of Aberdeen, the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh and the Scottish National Blood Transfusion Service.
Islet cells – which occur naturally in the pancreas – produce insulin, which enables the body to store glucose. However, not enough of these cells can be provided by a single donor, so patients can wait months before a second pancreas becomes available.
The breakthrough, published in the journal Diabetes, could enable pancreatic cells – other than islets – to be developed for transplant.
The effects would also be longer lasting than at present as more cells would be transplanted.
Islet cell transplants are given to Type 1 diabetics, who are unable to make insulin and are dependent on insulin injections.
John Casey, of the University of Edinburgh and also lead clinician for the National Islet Transplant Programme in Scotland, said: “There is a shortage of organ donors, which is not helped by the need for two pancreases to be donated to treat each diabetic patient.
“Developing previously unusable cells to produce insulin means that fewer donors would be needed, which would make a huge difference to patients waiting for transplants operations.”
The Latest on: Diabetes
- 'It comes down to pure greed': Insulin prices double, causing many people with diabetes to turn to extremeson December 10, 2019 at 4:01 pm
COLUMBUS, Ohio – Mindi Patterson’s family pays nearly $1,000 each month for insulin. Her husband, Roc, 47, and her two sons, 19-year-old Pierce and 14-year-old Martin, all have Type 1 diabetes and ...
- 'Diabetes burnout' is real, here's how to copeon December 10, 2019 at 1:35 pm
(HealthDay)—Living with diabetes—especially if you need insulin to survive—is a never-ending job that can be life-threatening if done wrong. That constant daily stress can lead to "diabetes burnout," ...
- Study: Weight loss may reduce type 2 diabetes risk by 37 percenton December 10, 2019 at 11:49 am
Dec. 10 (UPI) --Those with a family history of type 2 diabetes can still reduce their risk for developing the disease by maintaining a healthy weight, a new study has found. In new research published ...
- Lower BMI means lower diabetes risk, even among non-overweight peopleon December 10, 2019 at 11:03 am
Lower body mass index (BMI) is consistently associated with reduced type II diabetes risk, among people with varied family history, genetic risk factors and weight, according to a new study published ...
- Do Women With Diabetes Need More CVD Risk Reduction Than Men?on December 10, 2019 at 7:51 am
BUSAN, SOUTH KOREA — Whether cardiovascular disease risk reduction efforts should be more aggressive in women than men with the diabetes depends on how you interpret the data. Two experts came to ...
- FDA Investigating Diabetes Drug Metformin for Traces of Cancer-Linked Chemical NDMAon December 10, 2019 at 5:10 am
The U.S. Food and Drug Administration (FDA) is investigating whether a drug used to treat diabetes is contaminated with traces of a chemical thought to increase the risk of developing cancer. The ...
- Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatmenton December 10, 2019 at 2:22 am
Tuberculosis (TB) and type 2 diabetes mellitus (DM), a major TB risk factor, are both accompanied by marked alterations in metabolic processes. Dissecting the specific metabolic changes induced by ...
- Sanofi, Maker of World’s Top-Selling Insulin, to Exit Diabetes Researchon December 9, 2019 at 6:43 pm
Sanofi said it would stop investing in diabetes research after years of frustrated attempts to bring a fresh blockbuster to the market.
- Diabetes patients turning to black market as costs skyrocketon December 9, 2019 at 2:48 pm
Dec. 9 --Skyrocketing prices and insurance limits are driving many people with diabetes to seek medications and supplies from an underground supply chain, a new study found. "The cost of insulin, ...
- Sanofi ends research in diabetes, narrows units to spur profitson December 9, 2019 at 1:27 pm
Sanofi ( SASY.PA) on Monday said it would end its research efforts in diabetes and cardiovascular diseases as part of a reorganization plan that will narrow the number of its global business units in ...
via Google News and Bing News